Outcomes and Use of Therapeutic Drug Monitoring in Multidrug-Resistant Tuberculosis Patients Treated in Virginia, 2009-2014

BACKGROUND: Reports of therapeutic drug monitoring (TDM) for second-line medications to treat multidrug-resistant tuberculosis (MDR-TB) remain limited. METHODS: A retrospective cohort from the Virginia state tuberculosis (TB) registry, 2009-2014, was analyzed for TDM usage in MDR-TB. Drug concentrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Heysell, Scott K., Moore, Jane L., Peloquin, Charles A., Ashkin, David, Houpt, Eric R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Tuberculosis and Respiratory Diseases 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4388904/
https://www.ncbi.nlm.nih.gov/pubmed/25861340
http://dx.doi.org/10.4046/trd.2015.78.2.78

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4388904/
https://www.ncbi.nlm.nih.gov/pubmed/25861340
http://dx.doi.org/10.4046/trd.2015.78.2.78

Ejemplares similares